Considering the relatively high prevalence of hyperprolactinaemia and the clinical significance of lipid metabolism for clinical outcomes we recommend further studies to confirm our findings and elucidate the underlying pathophysiological mechanisms for the suggested link between prolactin and lipid metabolism. The gene discussed is PRL; the disease is Increased circulating prolactin concentration.